A carregar...
A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML
Acute myeloid leukemia (AML) is one of the most common hematological malignancies. It is difficult to treat since it easily develops resistance to therapeutic drugs. Myeloid cell leukemia 1 (MCL-1), BCL-2 and BCL-XL, which belong to the anti-apoptotic group of proteins in the BCL-2 family, are overe...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6781566/ https://ncbi.nlm.nih.gov/pubmed/31612056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10891 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|